Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-091026
Filing Date
2025-06-27
Accepted
2025-06-27 17:09:07
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 25285
  Complete submission text file 0000950170-25-091026.txt   26760
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REGULUS THERAPEUTICS INC. 4224 CAMPUS POINT CT., SUITE 210 SAN DIEGO CA 92121
Business Address
Rosen Hugh (Reporting) CIK: 0001672470 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 251087733